Relative performance can be a tricky metric to use when assessing whether a particular company's stock is getting its due in the market; significant factors like debt, margins and management's competence all make a difference. Nevertheless, the valuation on Huntsman (NYSE:HUN) puzzles me a bit, especially in relation to other chemical companies such as Albemarle (NYSE:ALB), Ashland (NSYE:ASH), Dow (NYSE:DOW) and BASF (OTC:BASFY). Although Huntsman has not fully executed a transition to a specialty chemicals company and there is a lot of debt here, this could be an interesting name to watch.
Please click on this link for more:
http://www.investopedia.com/
No comments:
Post a Comment